NanoString Technologies Inc.

199 articles with NanoString Technologies Inc.

• NanoString Technologies Inc. To Present At The Cowen and Company 35th Annual Health Care Conference

  2/19/2015

• NanoString Technologies Inc. To Release Fourth Quarter 2014 Financial Results And Host Conference Call On Tuesday, February 24, 2015

  2/11/2015

• NanoString Technologies Inc. To Present At 2015 Leerink Global Healthcare Conference

  1/28/2015

• NanoString Technologies Inc. Provides Update On 2014 Operational and Preliminary Financial Results

  1/9/2015

• NanoString Technologies Inc. To Present At J.P. Morgan 33rd Annual Healthcare Conference

  12/22/2014

• NanoString Technologies Inc. Highlights Important Results From Prosigna Decision Impact Study Presented At The 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium

  12/16/2014

• NanoString Technologies Inc. Updates Prosigna FDA Labeling To Provide Greater Insight Into Probability Of Breast Cancer Recurrence Between Year 5 And 10 After Diagnosis

  12/9/2014

• NanoString Technologies Inc. Announces Prosigna Presentations At The 2014 CTRC-AACR San Antonio Breast Cancer Symposium

  12/2/2014

• NanoString Technologies Inc. To Present At Canaccord Genuity Medical Technology And Diagnostics Forum

  11/7/2014

• NanoString Technologies Inc. Releases Financial Results For Third Quarter Of 2014

  11/5/2014

• NanoString Technologies Inc. Announces Publication In The Journal Of Clinical Oncology Showing The Prosigna Assay Identifies Women With A Low Risk Of Late Distant Recurrence Of Breast Cancer

  10/22/2014

• NanoString Technologies Inc. To Release Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 4, 2014

  10/10/2014

• NanoString Technologies Inc. Collaborates With Brigham and Women's Hospital In Boston To Accelerate Translation Of Genomic Discoveries Into Clinical Diagnostics In Oncology

  10/7/2014

• NanoString Technologies Inc. Introduces Novel Gene Expression Panel For Immuno-Oncology Research

  9/10/2014

• NanoString Technologies Inc. Announces Unexpected Death Of Chief Medical Officer, J. Wayne Cowens, MD

  8/27/2014

• NanoString Technologies Inc. To Present At Upcoming Investor Conferences

  8/21/2014

• NanoString Technologies Inc. Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay

  8/6/2014

• NanoString Technologies Inc. Releases Financial Results For Second Quarter Of 2014

  8/5/2014

• NanoString Technologies Inc. Introduces New Universal Junction Probe Design For Detecting Gene Fusions

  7/29/2014

• NanoString Technologies Inc., Celgene Corporation Strike $45 Million Companion Diagnostic Pact

  6/5/2014